Release Date: 06/03/23 10:27 Summary: Units on Issue Disclosure - February 2023 Price Sensitive: No Download Document 213.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%